Management of Ventricular Arrhythmias in Heart Failure: Can Less Be More?

Eitan Frankel,Reginald Ho
DOI: https://doi.org/10.1007/s11886-024-02107-5
IF: 3.955
2024-08-01
Current Cardiology Reports
Abstract:Ventricular arrhythmias (VAs) affect many patients with heart failure and underlying structural heart disease and are associated with significant morbidity and mortality. Antiarrhythmic drugs are often the initial treatment, but medication alone often fails to sufficiently suppress VAs. While catheter ablation (CA) remains the gold standard for treatment of VAs, CA is an invasive procedure and can be associated with periprocedural complications including acute clinical decompensation. Thus, there is an important need for alternative therapies.
cardiac & cardiovascular systems
What problem does this paper attempt to address?